Cytodyn Inc
OTC:CYDY
Cytodyn Inc
Change in Deffered Taxes
Cytodyn Inc
Change in Deffered Taxes Peer Comparison
Competitive Change in Deffered Taxes Analysis
Latest Figures & CAGR of Competitors
Company | Change in Deffered Taxes | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Cytodyn Inc
OTC:CYDY
|
Change in Deffered Taxes
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Change in Deffered Taxes
-$3B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Change in Deffered Taxes
-$1.4B
|
CAGR 3-Years
-91%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-26%
|
|
Amgen Inc
NASDAQ:AMGN
|
Change in Deffered Taxes
-$1.6B
|
CAGR 3-Years
-77%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Change in Deffered Taxes
-$581.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
17%
|
CAGR 10-Years
-14%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Change in Deffered Taxes
-$811.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|